Bone Morphogenetic Proteins (BMPs) are essential regulators of cartilage and bone formation, and understanding their functions in skeletal tissues is crucial to the development of effective therapies for skeletal maintenance and repair. The expression of multiple BMPs in skeletal tissues suggests that these ligands may serve overlapping functions and/or different members play distinct roles in cartilage and bone. Recent studies support each of these possibilities, and raise the additional complexity that a single BMP ligand can have diverse effects, depending on the receptor to which it binds. Specificity of BMP action is thought to be achieved in part by differential affinities of BMP ligands for one of three type I BMP receptors. Moreover, a single BMP acting through a single type of receptor may have diverse effects, depending on the level of receptor activation. Thus, while in vitro studies have been used to great advantage to define the range of activities that can be regulated by BMPs, identifying the physiological roles these growth factors play in cartilage and bone can only be achieved through in vivo studies. In vivo studies utilizing strains of mice deficient in BMP receptors form the basis of this proposal. Mice deficient in BmprIB, and mice carrying a hypomorphic allele of BmprII (BmprIIdeltaE2) will be utilized. In particular, BmprII-/- mice develop severe osteoarthritis, permitting an analysis of the role of BMP signaling pathways in articular cartilage in vivo. The proposed studies will utilize mice carrying a """"""""floxed"""""""" allele of BmprIA (BmprIAfx), which allows this gene to be eliminated in cartilage using Cre/loxP technology, to test the hypothesis that BmprIA and BmprIB exhibit overlapping and unique functions in vivo. All of the strains needed to test this hypothesis have been obtained. The Principal Investigator will also generate mice carrying a floxed allele of ActrI to test the hypothesis that this receptor has unique and essential functions in skeletal tissues. Finally, BmprIIdeltaE2/deltaE2 mice, which are homozygous for a putative hypomorphic (reduced function) allele, exhibit defects in axial patterning and delayed osteogenesis throughout the skeleton. The Principal Investigator will generate a floxed null allele of BmprII using Cre/lox technology. The resulting allelic series will be used to test the hypothesis that different levels of receptor activation cause different cellular responses in cartilage. These experiments are likely to uncover previously unsuspected roles for BMP signaling pathways in cartilage, and to lead to more specific and effective therapies for diseases such as osteoarthritis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR044528-05
Application #
6511887
Study Section
Special Emphasis Panel (ZRG1-OBM-2 (04))
Program Officer
Sharrock, William J
Project Start
1998-04-01
Project End
2006-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
5
Fiscal Year
2002
Total Cost
$305,250
Indirect Cost
Name
University of California Los Angeles
Department
Orthopedics
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Wang, Weiguang; Song, Buer; Anbarchian, Teni et al. (2016) Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate. PLoS Genet 12:e1006352
Rigueur, Diana; Brugger, Sean; Anbarchian, Teni et al. (2015) The type I BMP receptor ACVR1/ALK2 is required for chondrogenesis during development. J Bone Miner Res 30:733-41
Nishida, Takashi; Kubota, Satoshi; Aoyama, Eriko et al. (2015) CCN family protein 2 (CCN2) promotes the early differentiation, but inhibits the terminal differentiation of skeletal myoblasts. J Biochem 157:91-100
Wang, Weiguang; Rigueur, Diana; Lyons, Karen M (2014) TGF? signaling in cartilage development and maintenance. Birth Defects Res C Embryo Today 102:37-51
Weinstein, Michael M; Tompson, Stuart W; Chen, Yuqing et al. (2014) Mice expressing mutant Trpv4 recapitulate the human TRPV4 disorders. J Bone Miner Res 29:1815-1822
Rigueur, Diana; Lyons, Karen M (2014) Whole-mount skeletal staining. Methods Mol Biol 1130:113-121
Güemes, Miriam; Garcia, Alejandro J; Rigueur, Diana et al. (2014) GATA4 is essential for bone mineralization via ER? and TGF?/BMP pathways. J Bone Miner Res 29:2676-87
Ascenzi, Maria-Grazia; Du, Xia; Harding, James I et al. (2014) Automated Cell Detection and Morphometry on Growth Plate Images of Mouse Bone. Appl Math (Irvine) 5:2866-2880
Estrada, Kristine D; Wang, Weiguang; Retting, Kelsey N et al. (2013) Smad7 regulates terminal maturation of chondrocytes in the growth plate. Dev Biol 382:375-84
Merrill, Amy E; Sarukhanov, Anna; Krejci, Pavel et al. (2012) Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling. Am J Hum Genet 90:550-7

Showing the most recent 10 out of 33 publications